my Live Signal
my Live Signal
Source link
Similar Posts
MCX among 3 stocks to go ex-date for bonus issue, stock split next week. Do you own any? – Corporate actions next week
Corporate actions such as stock splits, bonus issues, and face value consolidations play a key role in reshaping a company’s capital structure and can significantly influence stock liquidity, investor participation, and short-term price movements. These events, while not impacting a company’s core fundamentals, often serve as triggers for renewed investor interest, particularly among retail participants….
The best scalping strategy for quick profit
The Best Scalping Strategy for Quick Profit Introduction to Scalping in Trading What is Scalping? Scalping is a trading strategy that involves making numerous trades throughout the day to capitalize on small price fluctuations. The primary goal is to “scalp” small profits consistently, enhancing the overall profit margins. Importance of a…
Setting new standards of Ethics and Robustness in algo trading
In the world of trading algorithms, transparency, and ethical practices are often compromised. Competitors may use to sell recklessly: 📌 Over-Optimization (Curve Fitting) 📌 Cherry-Picking Data 📌 Manipulating Stop-Losses & Take-Profits 📌 Excluding Slippage & Spread Costs 📌 Hiding Drawdowns … Check here to know how not to be fooled when you buy an algo. As a result, traders are left…
S&P 500, Nasdaq near record highs, Dow Jones soars 500 points on Israel-Iran ceasefire hopes
Wall Street’s S&P 500 neared a record high on Tuesday as President Donald Trump announced an Israel-Iran ceasefire and Federal Reserve Chair Jerome Powell reiterated interest-rate cuts can wait till the impact of tariffs becomes clearer. The benchmark S&P 500 index and the Nasdaq were about 1.1% and 1.5% below their all-time highs, respectively. At…
Kroger plans to name ex-Walmart executive Greg Foran as next CEO, WSJ reports
Kroger plans to name ex-Walmart executive Greg Foran as next CEO, WSJ reports Source link
CMS Slashes Prices Of 15 Major Drugs – Here’s Why Pharma Valuations Won’t Suffer
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston BioHealth. The group is for both novice and experienced biotech investors. It provides…
